Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Transl Med ; 12(1): e725, 2022 01.
Artigo em Inglês | MEDLINE | ID: mdl-35090098

RESUMO

Triple-negative breast cancer (TNBC) is fast-growing and highly metastatic with the poorest prognosis among the breast cancer subtypes. Inactivation of glycogen synthase kinase 3 beta (GSK3ß) plays a vital role in the aggressiveness of TNBC; however, the underlying mechanism for sustained GSK3ß inhibition remains largely unknown. Here, we find that protein phosphatase 1 regulatory inhibitor subunit 14C (PPP1R14C) is upregulated in TNBC and relevant to poor prognosis in patients. Overexpression of PPP1R14C facilitates cell proliferation and the aggressive phenotype of TNBC cells, whereas the depletion of PPP1R14C elicits opposite effects. Moreover, PPP1R14C is phosphorylated and activated by protein kinase C iota (PRKCI) at Thr73. p-PPP1R14C then represses Ser/Thr protein phosphatase type 1 (PP1) to retain GSK3ß phosphorylation at high levels. Furthermore, p-PPP1R14C recruits E3 ligase, TRIM25, toward the ubiquitylation and degradation of non-phosphorylated GSK3ß. Importantly, the blockade of PPP1R14C phosphorylation inhibits xenograft tumorigenesis and lung metastasis of TNBC cells. These findings provide a novel mechanism for sustained GSK3ß inactivation in TNBC and suggest that PPP1R14C might be a potential therapeutic target.


Assuntos
Glicogênio Sintase Quinase 3 beta/efeitos dos fármacos , Peptídeos e Proteínas de Sinalização Intracelular/genética , Neoplasias de Mama Triplo Negativas/genética , Progressão da Doença , Feminino , Glicogênio Sintase Quinase 3 beta/genética , Humanos , Peptídeos e Proteínas de Sinalização Intracelular/efeitos adversos , Neoplasias de Mama Triplo Negativas/tratamento farmacológico , Neoplasias de Mama Triplo Negativas/metabolismo
2.
Mol Cancer Res ; 18(1): 140-152, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31624086

RESUMO

Enhancer (ENH)-associated long noncoding RNAs (lncRNA) are a peculiar class of RNAs produced by transcriptionally active ENHs, owning potential gene-regulatory function. Here, we characterized RAIN, a novel ENH-associated lncRNA. Analysis of RAIN expression in a retrospective cohort of human thyroid cancers showed that the expression of this lncRNA is restricted to cancer cells and strongly correlates with the expression of the cancer-promoting transcription factor RUNX2. We showed that RAIN, serving as a cis-regulatory element, promotes RUNX2 expression by two mechanisms. Binding WDR5 and facilitating its localization on the RUNX2 promoter, RAIN modifies the transcriptional status of the RUNX2 locus facilitating transcription initiation. In parallel, RAIN acts as decoy for negative elongation factor complex, restraining its inhibitory function on transcription elongation. In both thyroid and breast cancer cells, RAIN promotes oncogenic features. Using RNA-sequencing profiling, we showed that RAIN orchestrates the expression of a network of cancer-promoting transcription regulators, suggesting that RAIN affects cancer cell phenotype by coordinating the expression of a complex transcriptional network. IMPLICATIONS: Our data contribute to understand lncRNA function in gene regulation and to consolidate their role in cancer.


Assuntos
Neoplasias da Mama/genética , Subunidade alfa 1 de Fator de Ligação ao Core/metabolismo , Peptídeos e Proteínas de Sinalização Intracelular/efeitos adversos , RNA Longo não Codificante/genética , Neoplasias da Glândula Tireoide/genética , Técnicas de Cultura de Células , Linhagem Celular Tumoral , Feminino , Humanos , Masculino
3.
Peptides ; 37(1): 161-4, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22771311

RESUMO

Orexins have been implicated in the regulation of sleep-wake cycle, energy homeostasis, drinking behavior, analgesia, attention, learning and memory but their effects on epileptic activity are controversial. We investigated whether intracortical injections of orexin A (100 pmol) and B (100 pmol) cause epileptic activity in rats. We observed epileptic seizure findings on these two groups rats. Orexin A and B also significantly increased total EEG power spectrum. Our findings indicate that orexins cause epileptic activity.


Assuntos
Epilepsia/induzido quimicamente , Peptídeos e Proteínas de Sinalização Intracelular/efeitos adversos , Neuropeptídeos/efeitos adversos , Neurotransmissores/efeitos adversos , Animais , Modelos Animais de Doenças , Eletroencefalografia , Epilepsia/fisiopatologia , Injeções Intraventriculares , Peptídeos e Proteínas de Sinalização Intracelular/administração & dosagem , Masculino , Neuropeptídeos/administração & dosagem , Neurotransmissores/administração & dosagem , Orexinas , Ratos , Ratos Wistar
4.
Peptides ; 34(2): 419-22, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22394654

RESUMO

Orexins have been implicated with physiological function including sleep-wake cycle, energy homeostasis, drinking behavior, analgesia, attention, learning and memory but their effects on excitability are controversial. We investigated the effects of intracortical injections of orexin A (100 pmol) and B (100 pmol) on the electrophysiological manifestation of epileptic seizures induced by cortical penicillin application in adult male rats. In comparison to saline, orexin A and B enhanced significantly the spike number, spike amplitude and spectral power values induced by cortical penicillin. Our findings indicates that orexins enhances the hyperexcitable and hypersyncronic cortical epileptic activity induced by focal application of penicillin-G.


Assuntos
Comportamento Animal/efeitos dos fármacos , Córtex Cerebral/efeitos dos fármacos , Epilepsia/fisiopatologia , Peptídeos e Proteínas de Sinalização Intracelular/efeitos adversos , Neuropeptídeos/efeitos adversos , Animais , Córtex Cerebral/fisiopatologia , Eletroencefalografia , Epilepsia/induzido quimicamente , Infusões Intraventriculares , Peptídeos e Proteínas de Sinalização Intracelular/administração & dosagem , Masculino , Neuropeptídeos/administração & dosagem , Neurotransmissores/administração & dosagem , Neurotransmissores/efeitos adversos , Orexinas , Penicilina G/administração & dosagem , Penicilina G/efeitos adversos , Ratos , Ratos Wistar
5.
Physiol Behav ; 93(4-5): 947-51, 2008 Mar 18.
Artigo em Inglês | MEDLINE | ID: mdl-18262574

RESUMO

The hypocretins, also known as orexins, are two neuropeptides now commonly described as critical components to maintain and regulate the stability of arousal. Several lines of evidence have raised the hypothesis that hypocretin-producing neurons are part of the circuitries that mediate the hypothalamic response to acute stress. Intracerebral administration of hypocretin leads to a dose-related reinstatement of drug and food seeking behaviors. Furthermore, stress-induced reinstatement can be blocked with hypocretin receptor 1 antagonism. These results, together with recent data showing that hypocretin is critically involved in cocaine sensitization through the recruitment of NMDA receptors in the ventral tegmental area, strongly suggest that activation of hypocretin neurons play a critical role in the development of the addiction process. The activity of hypocretin neurons may affect addictive behavior by contributing to brain sensitization or by modulating the brain reward system. Hypocretinergic cells, in coordination with brain stress systems may lead to a vulnerable state that facilitates the resumption of drug seeking behavior. Hence, the hypocretinergic system is a new drug target that may be used to prevent relapse of drug seeking.


Assuntos
Nível de Alerta/efeitos dos fármacos , Comportamento Aditivo/induzido quimicamente , Peptídeos e Proteínas de Sinalização Intracelular/efeitos adversos , Neuropeptídeos/efeitos adversos , Animais , Nível de Alerta/fisiologia , Humanos , Peptídeos e Proteínas de Sinalização Intracelular/farmacologia , Neuropeptídeos/farmacologia , Orexinas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...